Vialwirebiotech, curated
November 21, 2026, 7:38 AM
October 23, 2026
- 7:01 PM · Bloomberg — Technology7:01 PMUK Vows £100 Million for Biosecurity Lab With OpenAI, Anthropic — Bloomberg — Technology
- 4:06 PM · Pharmaceutical Executive4:06 PM<![CDATA[FDA Approves Subcutaneous Induction for Skyrizi in Crohn's Disease]]> — Pharmaceutical Executive
- 2:55 PM · STAT News2:55 PMSTAT+: Patient dies in Bristol Myers Squibb autoimmune CAR-T trial — STAT News
- 12:47 PM · STAT News12:47 PMNovartis multiple sclerosis treatment cuts rates of relapse in pivotal trials — STAT News
- 12:00 PM · BioWorld12:00 PMRare diseases specialist Ambrose acquiring AM-Pharma in €161M deal — BioWorld
- 12:00 PM · BioWorld12:00 PMGlobal drug approvals jump 50% as FDA hits 2026 monthly high — BioWorld
- 12:00 PM · BioWorld12:00 PMStar adjusts its orbit with $200M for preclinical pipeline — BioWorld
- 12:00 PM · BioWorld12:00 PMIPO surge continues with Lycia pricing upsized $317M offering — BioWorld
- 12:00 PM · BioWorld12:00 PMFractyl bets it all on Revita therapy to maintain weight loss — BioWorld
- 11:24 AM · STAT News11:24 AMSTAT+: Tango builds on Revolution Medicines’ pancreatic cancer success — STAT News
- 10:03 AM · STAT News
- 9:00 AM · BioWorld9:00 AMGeorgiamune draws Menarini in potential $1.1B preclinical deal — BioWorld
- 9:00 AM · STAT News
- 7:00 AM · Drug Discovery World7:00 AMMicrobiotica raises £36 million to advance into Phase II — Drug Discovery World
- 6:30 AM · STAT News
- 5:32 AM · Pharmaceutical Technology5:32 AMBoehringer and Microsoft collaborate to explore AI in clinical research — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMOMass closes $310m oversubscribed financing round — Drug Discovery World
- 4:46 AM · Pharmaceutical Technology4:46 AMCelltrion and Kaigene sign $580m licence deal for KG013 — Pharmaceutical Technology
- 4:00 AM · Drug Discovery World4:00 AMJ&J reports positive results for Tremfya — Drug Discovery World
- 3:45 AM · STAT News3:45 AMSTAT+: Alnylam says Huntington’s drug shows promise in early study — STAT News
- 12:00 AM · FT — Pharmaceuticals12:00 AMChina’s rapid human trials draw western drugmakers — and safety concerns — FT — Pharmaceuticals
October 22, 2026
- 7:12 PM · STAT News
- 5:56 PM · SCMP — Tech5:56 PMChina-made cancer drug to go on sale in US after Americans travel to buy it — SCMP — Tech
- 4:37 PM · BioWorld4:37 PMBiohaven rises on FDA acceptance of troriluzole NDA resubmission — BioWorld
- 3:03 PM · STAT News
- 2:22 PM · STAT News
- 12:00 PM · BioWorld12:00 PMAlpha male in HS? Abbvie phase III data subdue Avalo shares — BioWorld
- 12:00 PM · BioWorld12:00 PMFDA launches Alzheimer’s initiative as HHS updates national plan — BioWorld
- 12:00 PM · BioWorld12:00 PMWill Qiagen shareholders be tempted by EQT's €10.8B offer? — BioWorld
- 12:00 PM · BioWorld12:00 PMUK opens national Alzheimer’s trial to test approved, novel drugs — BioWorld
- 11:50 AM · BioPharma Dive11:50 AMGLP-1 compounder issues recall for copycat Zepbound — BioPharma Dive
- 11:30 AM · Bloomberg — Technology11:30 AMEx-OpenAI Science Head Kevin Weil Launches Startup With $215 Million — Bloomberg — Technology
- 11:20 AM · BioPharma Dive11:20 AMRoche affirms sales outlook amid doubts about its future — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMEANM 2026: Early data on CAIX-targeted radiopharmaceutical for ccRCC — BioWorld
- 9:00 AM · BioWorld9:00 AMOrikine’s ORK-1 exerts disease control in IBD models — BioWorld
- 9:00 AM · BioWorld9:00 AMOpus Genetics gains IND clearance for OPGx-RDH12 — BioWorld
- 9:00 AM · BioWorld9:00 AMMolecular Partners selects MP-0730 as radiotherapeutic candidate — BioWorld
- 9:00 AM · BioWorld9:00 AMArbor Biotechnologies nominates gene editing candidates for ALS — BioWorld
- 9:00 AM · BioWorld9:00 AMRyvu’s RVU-602 shows potential as pan-cancer ADC payload — BioWorld